Skip to main navigation

HOME
ABOUT ENZON
ROYALTY PRODUCTS
INVESTORS & MEDIA
Investor Relations
CONTACT US

Request Information
Email Alerts
Download Library
RSS News Feeds

Shareholder Tools

Downloads

Print

Downloads

Categories

Year

Apr 17, 2007

Enzon's PEG-SN38 Shows Anti-Tumor Activity in Resistant Preclinical Tumor Models 15 KB

Apr 12, 2007

Enzon to Present Preclinical Data From PEG-SN38 and PEGylation Technology Studies at AACR Meeting 10.7 KB

Mar 29, 2007

Enzon Enrolls First Patient in Phase 1 Study of Its HIF-1 Alpha Antagonist 11.6 KB

Mar 06, 2007

Enzon to Present at Cowen 27th Annual Health Care Conference 8.4 KB

Feb 13, 2007

Enzon Reports 2006 Financial Results and Accomplishments 38.6 KB

Feb 02, 2007

Enzon Announces Consolidation of Its Manufacturing Operations in Indianapolis 11 KB

Jan 31, 2007

Enzon to Release Earnings on Tuesday February 13, 2007; Conference Call and Webcast to Follow 8.1 KB

Jan 25, 2007

Enzon Receives FDA Clearance of HIF-1 alpha Investigational New Drug Application 11.3 KB

Jan 10, 2007

Enzon Announces CEO Cancer Gold Standard Accreditation 11.1 KB

Jan 04, 2007

Enzon Pharmaceuticals Secures Supply of Oncaspar 11.8 KB

Pagination

First page
Previous page
…
Page 11
Page 12
Page 13
Page 14
Page 15
Current page 16
Page 17
Page 18
Page 19
Next page
Last page

©2025 Enzon Pharmaceuticals, Inc., All Rights Reserved.